BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wehbe Z, Wehbe M, Iratni R, Pintus G, Zaraket H, Yassine HM, Eid AH. Repurposing Ivermectin for COVID-19: Molecular Aspects and Therapeutic Possibilities. Front Immunol 2021;12:663586. [PMID: 33859652 DOI: 10.3389/fimmu.2021.663586] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Louten J. Coronaviruses. Essential Human Virology 2023. [DOI: 10.1016/b978-0-323-90565-7.00014-9] [Reference Citation Analysis]
2 Chen YT, Chang YH, Pathak N, Tzou SC, Luo YC, Hsu YC, Li TN, Lee JY, Chen YC, Huang YW, Yang HJ, Hsu NY, Tsai HP, Chang TY, Hsu SC, Liu PC, Chin YF, Lin WC, Yang CM, Wu HL, Lee CY, Hsu HL, Liu YC, Chu JW, Wang LH, Wang JY, Huang CH, Lin CH, Hsieh PS, Wu Lee YH, Hung YJ, Yang JM. Methotrexate inhibition of SARS-CoV-2 entry, infection and inflammation revealed by bioinformatics approach and a hamster model. Front Immunol 2022;13:1080897. [PMID: 36618412 DOI: 10.3389/fimmu.2022.1080897] [Reference Citation Analysis]
3 Nandi S, Nayak BS, Khede MK, Saxena AK. Repurposing of Chemotherapeutics to Combat COVID-19. Curr Top Med Chem 2022;22:2660-94. [PMID: 36453483 DOI: 10.2174/1568026623666221130142517] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Said SA, Abdulbaset A, El-kholy AA, Besckales O, Sabri NA. The effect of Nigella sativa and vitamin D3 supplementation on the clinical outcome in COVID-19 patients: A randomized controlled clinical trial. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.1011522] [Reference Citation Analysis]
5 Brady DK, Gurijala AR, Huang L, Hussain AA, Lingan AL, Pembridge OG, Ratangee BA, Sealy TT, Vallone KT, Clements TP. A guide to COVID-19 antiviral therapeutics: a summary and perspective of the antiviral weapons against SARS-CoV-2 infection. FEBS J 2022. [PMID: 36266238 DOI: 10.1111/febs.16662] [Reference Citation Analysis]
6 du Preez HN, Aldous C, Kruger HG, Johnson L. N-Acetylcysteine and Other Sulfur-Donors as a Preventative and Adjunct Therapy for COVID-19. Advances in Pharmacological and Pharmaceutical Sciences 2022;2022:1-21. [DOI: 10.1155/2022/4555490] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Fraccaroli L, Ruiz MD, Perdomo VG, Clausi AN, Balcazar DE, Larocca L, Carrillo C. Broadening the spectrum of ivermectin: Its effect on Trypanosoma cruzi and related trypanosomatids. Front Cell Infect Microbiol 2022;12:885268. [DOI: 10.3389/fcimb.2022.885268] [Reference Citation Analysis]
8 Yang S, Shen S, Hou N. Is Ivermectin Effective in Treating COVID-19? Front Pharmacol 2022;13:858693. [DOI: 10.3389/fphar.2022.858693] [Reference Citation Analysis]
9 Zhang R, Oerlemans R, Wang C, Zhang L, R. Groves M. Drug Repurposing Techniques in Viral Diseases. Drug Repurposing - Molecular Aspects and Therapeutic Applications 2022. [DOI: 10.5772/intechopen.101443] [Reference Citation Analysis]
10 Wang Z, Hu N, Zhou Y, Shi N, Shen B, Luo L, Feng J. Structure-guided affinity maturation of a novel human antibody targeting the SARS-CoV-2 nucleocapsid protein. Sci Rep 2022;12:8469. [PMID: 35589780 DOI: 10.1038/s41598-022-12242-0] [Reference Citation Analysis]
11 Qabbus MB, Hunt KS, Dynka J, Woodworth CD, Sur S, Samways DS. Ivermectin-induced cell death of cervical cancer cells in vitro a consequence of precipitate formation in culture media. Toxicology and Applied Pharmacology 2022. [DOI: 10.1016/j.taap.2022.116073] [Reference Citation Analysis]
12 Gupta D, Awadhiya O, Saigal S, Kumar A. Structure, genomic analysis, and pathogenesis of SARS-CoV-2. Advanced Biosensors for Virus Detection 2022. [DOI: 10.1016/b978-0-12-824494-4.00003-5] [Reference Citation Analysis]
13 Shimizu K, Hirata H, Kabata D, Tokuhira N, Koide M, Ueda A, Tachino J, Shintani A, Uchiyama A, Fujino Y, Ogura H. Ivermectin administration is associated with lower gastrointestinal complications and greater ventilator-free days in ventilated patients with COVID-19: A propensity score analysis. J Infect Chemother 2021:S1341-321X(21)00360-3. [PMID: 35016823 DOI: 10.1016/j.jiac.2021.12.024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Low ZY, Yip AJW, Lal SK. Repositioning Ivermectin for Covid-19 treatment: Molecular mechanisms of action against SARS-CoV-2 replication. Biochim Biophys Acta Mol Basis Dis 2021;1868:166294. [PMID: 34687900 DOI: 10.1016/j.bbadis.2021.166294] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
15 Sonkar C, Doharey PK, Rathore AS, Singh V, Kashyap D, Sahoo AK, Mittal N, Sharma B, Jha HC. Repurposing of gastric cancer drugs against COVID-19. Comput Biol Med 2021;137:104826. [PMID: 34537409 DOI: 10.1016/j.compbiomed.2021.104826] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
16 Cruciani M, Pati I, Masiello F, Malena M, Pupella S, De Angelis V. Ivermectin for Prophylaxis and Treatment of COVID-19: A Systematic Review and Meta-Analysis. Diagnostics (Basel) 2021;11:1645. [PMID: 34573986 DOI: 10.3390/diagnostics11091645] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
17 Khan M, Singh GK, Abrar S, Ganeshan R, Morgan K, Harky A. Pharmacotherapeutic agents for the management of COVID-19 patients with preexisting cardiovascular disease. Expert Opin Pharmacother 2021;:1-20. [PMID: 34464223 DOI: 10.1080/14656566.2021.1960311] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Younis NK, Zareef RO, Fakhri G, Bitar F, Eid AH, Arabi M. COVID-19: potential therapeutics for pediatric patients. Pharmacol Rep 2021. [PMID: 34458951 DOI: 10.1007/s43440-021-00316-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
19 Jordan V. Cochrane Corner: Coronavirus (COVID-19): does Ivermectin prevent transmission or aid in the treatment of COVID-19? J Prim Health Care 2021;13:287. [DOI: 10.1071/hc19563] [Reference Citation Analysis]